Cancellation of state registration. Nikoshpan®

October 26, 2017
Trade names:
ICD-10:
VI.G40-G47.G43    Migraine
IX.I70-I79.I73.0    Raynaud's syndrome
IX.I70-I79.I73.1    Obliterating thromboangitis [Berger's disease]
IX.I70-I79.I73.9    Peripheral vascular disease, unspecified
Nikoshpa, improvement of cerebral circulation, migraine, obliterating endarteritis, vasodilator drug

The Ministry of Health of the Russian Federation in accordance with Article 32 of the Federal Law of 12.04.2010 No. 61-FZ "On the circulation of medicinal products" decided to abolish state registration and exclusion from the stateRegister of medicinal products for medical use of the medicinal product (registration certificate P N015060 / 01-2003 dated 02.06.2008 issued by Hinoin Pharmaceutical and Chemical Products Plant AO, Hungary):

Nikoshpan® (trade name of the medicinal product)

- (international non-proprietary or grouping or chemical name)

pills (dosage form, dosage)

Hinoin Pharmaceutical and Chemical Products Plant AO, Hungary 2112, Veresegyhaz, Levai u. 5, Hungary (name and address of the location of the manufacturer of the medicinal product)

on the basis of an application by the authorized legal entity of the Sanofi-Aventis Group JSC to cancel the state registration of the medicinal product.